The rise of high-end imaging technologies like MRI and CT hasusurped the role of conventional radiography as the modality ofchoice for many medical imaging applications. But one of the areasin which conventional radiography will retain its value is
The rise of high-end imaging technologies like MRI and CT hasusurped the role of conventional radiography as the modality ofchoice for many medical imaging applications. But one of the areasin which conventional radiography will retain its value is inguiding interventional procedures, according to Arnold Arsenault,marketing manager of the x-ray products division of Shimadzu MedicalSystems.
At the 1992 RSNA meeting, Gardena, CA-based Shimadzu unveiledPangiomax ER-1000, a high-end angiography system designed to capitalizeon radiography's interventional utility.
"A lot of people are talking about x-ray disappearing,"Arsenault said. "It's definitely changing, there's no questionabout it. (Other modalities) will replace the diagnostic capabilityof x-ray. But what x-ray is going to turn into is the therapeuticarea. For example, (a diagnosis) will be done on MR, but insteadof bringing you into surgery, they'll bring you into x-ray anddo an interventional procedure to correct the problem."
ER-1000 was originally designed as a dedicated neurointerventionalunit and received Food and Drug Administration marketing clearancein 1991. Shortly after receiving FDA approval, however, Shimadzudecided to redesign ER-1000 to perform whole-body angiographyprocedures.
"(ER-1000) had limitations because in the U.S. there aren'tthat many dedicated neuro sites," Arsenault said. "Welooked at how we could change it to do more than neuro work."
The redesign was accomplished by extending the guiderails onthe ceiling-suspended unit far enough to enable the image tubesto cover the entire body. No new FDA application was requiredfor the modification.
ER-1000 features a computerized auto-positioning system, whichprovides users with up to 50 pre-set positions that can speedstudies, according to the company.
ER-1000 is capable of performing biplane fluoroscopy and cutfilm exposure. Digital subtraction angiography is possible bycombining the ER-1000 with either Shimadzu's Digitex 2400 or DAR1200 digital acquisition consoles. The Digitex 2400 is Shimadzu'stop-of-the-line console and can be used to set both digital andx-ray parameters of a study.
The price of the ER-1000 without digital ranges from $700,000to $800,000.
ER-1000 exemplifies the company's emphasis on the therapeuticapplications of x-rays, according to Arsenault.
"Shimadzu believes that interventional is the way x-rayis going in the future," he said. "We're investing init from that standpoint."
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.